Viewing Study NCT05124561


Ignite Creation Date: 2025-12-24 @ 1:00 PM
Ignite Modification Date: 2026-01-14 @ 6:37 PM
Study NCT ID: NCT05124561
Status: WITHDRAWN
Last Update Posted: 2023-06-18
First Post: 2021-11-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Sponsor: CanSino Biologics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module